Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function

High-dose methotrexate (MTX; ≥1 g/m(2)) is a renally eliminated and nephrotoxic first-line therapy for central nervous system (CNS) lymphoma. Creatinine-based estimation of renal function is the recommended approach to dosing MTX in these cases, but nonrenal determinants of creatinine production and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Hematol
Hlavní autoři: Barreto, Jason N., McClanahan, Allison L., Rule, Andrew D., Thompson, Carrie A., Frazee, Erin
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892267/
https://ncbi.nlm.nih.gov/pubmed/29780646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7169897
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky